<DOC>
	<DOCNO>NCT01671410</DOCNO>
	<brief_summary>The opioid neonatal abstinence syndrome ( NAS ) condition withdrawal symptom utero exposure opioids . Sublingual buprenorphine show promise new treatment NAS . This trial investigate safety tolerability sublingual buprenorphine infant expose opioids benzodiazepine utero exposure opioids breastfeeding .</brief_summary>
	<brief_title>Buprenorphine Treatment Neonatal Abstinence Syndrome Infants With In Utero Exposure Benzodiazepines</brief_title>
	<detailed_description>Infants utero exposure opioids often require therapy morphine extend period . In clinical trial , sublingual buprenorphine reduce treatment period ~30 % . However , infant opioid benzodiazepine exposure include trial . This study test safety tolerability sublingual buprenorphine infant utero exposure benzodiazepine breastfeed .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Neonatal Abstinence Syndrome</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>1 . â‰¥ 37 week gestation 2 . Exposure opioids utero 3 . Demonstration sign symptom neonatal abstinence syndrome require treatment 4 . Exposure benzodiazepine utero and/or receive breast milk . Benzodiazepine use define maternal use past 30 day , and/or receipt benzodiazepine prescription ( determine selfreport intake urine ) mother 30 day prior birth . 1 . Major congenital malformation and/or intrauterine growth retardation define birth weight &lt; 2200 gm 2 . Medical illness require intensification medical therapy . This include , limited suspect sepsis require antibiotic therapy . 3 . Hypoglycemia require treatment intravenous dextrose 4 . Bilirubin &gt; 20 mg/dL ( The need phototherapy exclusionary ) 5 . Seizure activity neurologic abnormality</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Neonatal Abstinence Syndrome</keyword>
	<keyword>buprenorphine</keyword>
	<keyword>morphine</keyword>
	<keyword>benzodiazepine</keyword>
</DOC>